Daniel Patrick Mackey

Daniel Patrick Mackey has filed trades across 2 companies (mainly through Finansinspektionen), most often in Infant Bacterial Therapeutics AB and Infant Bacterial Therapeutics. In total, 3 filings cover trades dated from 27 November 2017 to 15 March 2021.

In open-market terms, that means 2 purchases worth €9,469 on one side and 1 sale worth €4,062 on the other. Purchases outweigh sales by €5,407. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2021 to date brings 1 purchase and 1 sale.

The latest filing, published on 17 March 2021, reports an open-market sale of €4,062 in Infant Bacterial Therapeutics AB. The last purchase on record was published on 17 March 2021, which is 2,044 days ago. The median gap between a trade and its publication by Finansinspektionen is 2 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.